InvestorsHub Logo
Followers 30
Posts 2200
Boards Moderated 0
Alias Born 09/01/2020

Re: dmb2 post# 435671

Monday, 01/17/2022 12:55:03 PM

Monday, January 17, 2022 12:55:03 PM

Post# of 732486
“There will most likely be slower approvals and platform development than hoped for, and, the best solution is for NWBO to partner asap. I think it is very doubtful they have submitted their BLA already“

Mostly agree with both your points. However, the age of the management and their experience suggests it will very likely be a buyout rather than partnership. I am not sure how long they want to continue at this age. It will be a long and challenging journey even with a partnership. Also, I am not sure if a big pharma investor (in case of a partnership) would trust the current NWBO management to execute in a timely fashion in the future (given the history) unless there is an agreement to bring new management. And in this case, why would the current management want to continue holding on to this much longer? The only reasonable explanation would be if they expect a much bigger pay day than what’s currently offered for a buyout.

Either way, regardless of how good a technology you have, if you don’t innovate, scale, and execute fast enough, competitors (new technologies) will catch up and you lose the edge. So I hope they do the right thing in the interest of patient community as soon as they get approvals.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News